These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18083012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH, Spohr M, Bauer D.
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [Abstract] [Full Text] [Related]

  • 5. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
    Nicoletti P, Mazzei T, Lamanna S.
    G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
    [No Abstract] [Full Text] [Related]

  • 6. [The "in vitro" susceptibility of pseudomonas aeruginosa to tobramycin (author's transl)].
    Fernández H, Otth L.
    Rev Med Chil; 1976 Jul; 104(7):473-4. PubMed ID: 828757
    [No Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin in vitro activity alone and in combination against clinical isolates of glucose nonfermenting bacteria.
    Marklein G, Lotze G, Ungerechts J.
    J Chemother; 1989 Jul; 1(4 Suppl):156-9. PubMed ID: 16312350
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR, Bourget C, Mainville S, Lafleur L, Lagacé J, Montplaisir S.
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
    Ceruti T, Bassi L, Biazzi E, Fasani AM, Pedroni P.
    Arch Sci Med (Torino); 1982 Jul; 139(4):463-5. PubMed ID: 6820271
    [Abstract] [Full Text] [Related]

  • 12. Postantibiotic effect and virulence factors depression induced by ciprofloxacin and by aminoglycosides in a clinical isolate of Pseudomonas aeruginosa.
    Hostacka A.
    Zentralbl Bakteriol; 1996 Mar; 283(3):322-7. PubMed ID: 8861870
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In-vitro effect of tobramycin].
    Jedlicková Z.
    Z Arztl Fortbild (Jena); 1977 Jul 01; 71(13):651-2. PubMed ID: 412333
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of ceftazidime and other antipseudomonal antibiotics against mucoid strains of pseudomonas aeruginosa.
    Christie CD, Baltimore RS.
    West Indian Med J; 1988 Jun 01; 37(2):87-91. PubMed ID: 3146165
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.